Showing results (961-970 of 5,345) with videos related to
Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|October 31, 2019
Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosteroneYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.Japanese Journal of Clinical Oncology|October 31, 2019
Efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy in breast-conserving surgery for early-stage breast cancer: a single-centre study in ChinaYin Mi, Pengwei Lv, Fang Wang, et al.Japanese Journal of Clinical Oncology|October 31, 2019
Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancerKenji TamuraJapanese Journal of Clinical Oncology|October 31, 2019
Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based populationTetsuya Ito, Koji Kono, Hidetaka Eguchi, et al.Japanese Journal of Clinical Oncology|November 27, 2020
Current status of cancer immunotherapy for gynecologic malignanciesHiroshi Nishio, Takashi Iwata, Daisuke AokiJapanese Journal of Clinical Oncology|November 30, 2020
Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysisMasato Yoshihara, Satoshi Tamauchi, Shohei Iyoshi, et al.Japanese Journal of Clinical Oncology|November 26, 2020
Current status of immunotherapy for advanced gastric cancerAkihito Kawazoe, Kohei Shitara, Narikazu Boku, et al.Japanese Journal of Clinical Oncology|September 4, 2014
Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancerShoji Nagao, Tadaaki Nishikawa, Tatsuya Hanaoka, et al.Japanese Journal of Clinical Oncology|September 5, 2014
Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical managementMariette Baud, Antonio Bobbio, Filippo Lococo, et al.Japanese Journal of Clinical Oncology|August 29, 2014
High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patientsTomoko Asano, Shinya Sato, Nobuyasu Yoshimoto, et al.Pageof 535